The data available to date, describing the role played by BCL2 in transitional cell carcinoma (TCC) of the bladder, have been both limited and conflicting, with some studies showing an association with a lower tumour grade (King et al, 1996) and less aggressive phenotype (Shiina et al, 1996). Here, BCL2 is linked to tarsal-carpal coalition syndrome.